CRYL1 (crystallin lambda 1)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
51084 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Crystallin lambda 1 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
CRYL1 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
GDH, HEL30, gul3DH, lambda-CRY |
Chromosome
Chromosome number
|
13 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
13q12.11 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme req |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | ||||||||||||||||
UniProt ID | Q9Y2S2 | |||||||||||||||
Protein name | Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) | |||||||||||||||
Protein function | Has high L-gulonate 3-dehydrogenase activity. It also exhibits low dehydrogenase activity toward L-3-hydroxybutyrate (HBA) and L-threonate. | |||||||||||||||
PDB | 3F3S | |||||||||||||||
Family and domains |
Pfam
|
|||||||||||||||
Tissue specificity | TISSUE SPECIFICITY: Widely expressed, with highest levels in liver and kidney. {ECO:0000269|PubMed:12527201}. | |||||||||||||||
Sequence | ||||||||||||||||
Sequence length | 319 | |||||||||||||||
Interactions | View interactions |
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|||||||||
|
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|